Associated Papers
Clinical Implications of Discrepancy between One-Stage Clotting and Chromogenic Factor IX Activity in Hemophilia B.
Schmidt DE et al.
Thrombosis and Haemostasis, 2024
Splicing dysregulation contributes to the pathogenicity of several F9 exonic point variants.
Katneni UK et al.
Molecular Genetics & Genomic Medicine, 2019
31257730 (PubMed )
Supplement: MGG3-7-e840-s002.xls › F9_Splicing_Data
Hemophilia B is a quasi-quantitative condition with certain mutations showing phenotypic plasticity.
Chavali S et al.
Genomics, 2009
Select a paper to view details